| Regulatory
Matters |
| |
Antipsychotics |
| |
Clopidogrel |
| |
Dextropropoxyphene/
propoxyphene-containing medicines |
| |
Erlotinib |
| |
Immunosuppressant
medicines |
| |
Mycophenolate
mofetil |
| |
Piroxicam |
| |
Varenicline
and bupropion |
| |
Zinc-containing
intranasal products |
|
Safety of Medicines |
| |
Cefepime |
| |
Chloral
hydrate and triclofos |
| |
Fentanyl
transdermal patches |
| |
Golimumab |
| |
Insulin
glargine |
| |
Latanoprost
and rosiglitazone |
| |
Leukotriene
inhibitors |
| |
Metformin |
| |
Omalizumab |
| |
Propylthiouracil |
| |
Sirolimus |
| |
Stimulant
medications |
| |
Topical
ketoprofen |
| |
Triamcinolone
acetonide |
| |
Tumour
necrosis factor inhibitors |
| Feature |
| |
Inspections
of Bio-Equivalence Studies |